Sardar, Saiqa, Rahman, Atta Ur, Khan, Bakhtawar, Khan, Muhammad Ajmal, Iqbal, Muhammad Khalid, Hasnain, Muhammad, Khan, Noor Zada, Ullah, Amin, Javed, Muhammad Arshad, and Ali, Qurban
Antibiotic resistance is presently one of the most critical global challenges to effectively treating bacterial infections. It has been shown to negatively impact both clinical and therapeutic outcomes, leading to treatment failures, the necessity for costly and safer alternative medications, increased morbidity and mortality rates, prolonged hospital stays, and substantial healthcare costs. The present anti-microbial therapy used against several infectious diseases, including urinary tract infections (UTIs), is not sufficient to combat the diseases. To overcome this antibiotic resistance, there is an urgency among researchers to identify or develop effective alternatives for anti-microbial therapy to delineate antibiotic resistance. The rising interest of the scientific community in the upcoming field of nanotechnology holds great potential. The current study aimed to evaluate the anti-microbial potential of Vaccinium macrocarpon–mediated iron-doped zinc oxide nanoparticles (NPs). The mid-stream urine specimens (n = 376) were collected with equal ratios from both male and female patients suspected of UTI and inoculated on suitable media. Out of a total 376, only 100 specimens showed growth of different bacteria, which were further proceeded for their antibiotic susceptibility. The frequency of Gram-negative bacteria was collectively higher (n = 78) than Gram positive bacteria (n = 22). Among these isolates, Escherichia coli was noted to be the most frequent uropathogens (33%) followed by Klebsiella pneumoniae (22%), Staphylococcus aureus (14%), Pseudomonas aueroginosa, while Enterococcus faecalis, and Proteus mirabilis were 8% and 6%, respectively. The least isolated pathogen was Providencia stuartii, accounted for 4%. The Gram-negative isolates such as K. pneumonia, E. coli, P. aeruginosa, and P. stuartii revealed the highest resistance to gentamicin (60.60%), (68.18%), (90.90%), and (60.0%), respectively. P. mirabilis showed 71.42% resistance to ciprofloxacin and cefotaxime. While S. aureus revealed 57.14% resistance to cefotaxime and gentamicin. Using co-precipitation techniques, the Fe-doped ZnO nanoparticles were synthesized and characterized using several analytical techniques. The crystallinity and hexagonal conformation were studied using XRD technique. The FTIR spectroscopy defines the conjugation of different phytochemicals and bonding configurations, and through TEM the morphology of the nanoparticles was investigated which was hexagonal with a 30-nm average size. The synthesized NPs were then tested against a few MDR uropathogenic bacteria using disc diffusion method where the meropenem was used as a control. The NPs exhibit anti-microbial response with zones of inhibition ranging between 10 and 21 mm, indicating that these NPs were bestowed with potent anti-microbial activity. The anti-bacterial activity of meropenem was quite higher than that of NPs and extract alone, but in THE case of S. aureus, it was noted less (18 ± 0.4) than NPs at 40 μg/ml (18 ± 0.6). In the current study, the higher anti-bacterial efficiency was noted against P. stuartii (21 ± 0.5), followed by, K. pneumonia (21 ± 0.4) at 40 μg/ml. The zone of inhibition was directly proportional to the concentration of NPs. The minimum inhibitory concentration (MIC) was found to be lowest for P. stuartii at 39 ± 1.6 μg/ml, for E. coli 41 ± 1.5 μg/ml, K. pneumoniae 43 ± 2.8 μg/ml, P. mirabilis 44 ± 0.8 μg/ml, and S. aureus 49 ± 1.7 μg/ml. The highest MIC was observed for P. aeruginosa (53 ± 2.4 μg/ml), with E. faecalis showing inhibition at 52 μg/ml. Therefore, from the current study, it could be concluded that Vaccinium macrocarpon–based Fe-ZnO nanoparticles can be used as potential nano-antibiotic sources for the therapy of UTIs as having better anti-microbial potential than the empiric antibiotics that are currently used to treat the UTIs. [ABSTRACT FROM AUTHOR]